Urinary biomarker of oxidative stress correlating with outcome in critically septic patients

Intensive Care Medicine

Volumn 33, Issue 7, 2007, Pages 1187-1190

  Cheng, Wei Erh ^a   Shih, Chuen Ming ^a   Hang, Liang Wen ^a   Wu, Kuen Yuh ^b   Yang, Hsin Ling ^c   Hsu, Wu Huei ^a   Hsia, Te Chun ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

8 Hydroxy 2 deoxyguanosine; Acute Physiology and Chronic Health Evaluation II; Outcome assessment; Oxidative stress; Sepsis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER;

ADULT; AGED; APACHE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE COURSE; FEMALE; HOSPITAL DISCHARGE; HUMAN; IN VIVO STUDY; INTENSIVE CARE UNIT; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARAMETER; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SURVIVOR; TANDEM MASS SPECTROMETRY; URINARY EXCRETION;

AGED; APACHE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; CRITICAL ILLNESS; DEOXYGUANOSINE; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; RADIOISOTOPE DILUTION TECHNIQUE; SEPSIS; TANDEM MASS SPECTROMETRY;

EID: 34447136278     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0628-9     Document Type: Article

References (19)

1. Friedman G, Silva E, Vincent J-LM (1998) Has the mortality of septic shock changed with time? Crit Care Med 26:2078-2086
2. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
3. Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469-487
4. Vega JMAD, Julian Diaz ES, Carbonell LF (2000) Plasma redox status relates to severity in critically ill patients. Crit Care Med 28:1812-1814
5. Vega JMAD, Diaz J, Serrano S, Carbonell LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30:1782-1786
6. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048-1052
7. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
8. Yin B, Whyatt RM, Petera FP, Randall MC, Cooper TB, Santella RM (1995) Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclocnal antibody-based ELISA. Free Radic Biol Med 18:1023-1032
9. Hu CW, Chao MR, Wu MT, Pan CH, Wang CJ, Swenberg JA, Wu KY (2004) Comparison of analyses of urinary 8-hydroxy-2-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun Mass Spectrom 18:1-6
10. Cheng WE, Hsia TC, Shih CM (2006) Urinary 8-hydroxydeoxyguanosine excretion relates to outcome of septic patients in medical intensive care unit. Proc Am Thorac Soc 3:A646
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
12. Pinsky MR (2004) Dysregulation of the immune response in severe sepsis. Am J Med Sci 328:220-229
13. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
14. Poulsen HE, Loft S, Prieme H, Vistisen K, Lykkesfeldt J, Nyyssonen K, Salonen JT (1998) Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Rad Res 29:565-571
15. Afessa B, Keegan MT, Mohammad Z, Finkielman JD, Peters SG (2004) Identifying Potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 126:1905-1909
16. Mishra V, Baines M, Wenstone R, Shenkin A (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42:269-276
17. Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76-84
18. Hedlund J, Hansson LO (2000) Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28:68-73
19. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand J-A, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524-2536